Redcliffe Labs Acquires Pune-Based Megavision Diagnostics for INR 40 Cr

As part of the transaction, Redcliffe Labs will retain Megavision Diagnostics’ entire workforce. The company said the move is intended to maintain continuity of patient care while expanding access to diagnostic services across the region.

Omnichannel diagnostics provider Redcliffe Labs has acquired Pune-based Megavision Diagnostics Center for approximately INR 40 crore, expanding its imaging capabilities and strengthening its integrated pathology and radiology offering in Maharashtra.

Megavision Diagnostics operates two MRI-equipped centers in Pune, adding advanced imaging infrastructure to Redcliffe Labs’ existing pathology network. The acquisition will allow the company to offer imaging and pathology services through a more integrated diagnostics platform.

As part of the transaction, Redcliffe Labs will retain Megavision Diagnostics’ entire workforce. The company said the move is intended to maintain continuity of patient care while expanding access to diagnostic services across the region.

The acquisition is part of Redcliffe’s broader network expansion through acquisitions and partnerships across key Indian markets. Over the past year, the company acquired Prime Sonography & Diagnostic Center in Kota and Sarvodaya Diagnostics in Ajmer. Both facilities now operate under the Redcliffe Medicentre Imaging & Labs network.

Redcliffe Labs said it has served more than 1 crore customers and operates across over 220 cities, with more than 80 owned laboratories and coverage spanning over 4,000 pincodes. Its diagnostic portfolio includes more than 3,600 tests.

The transaction comes amid increased consolidation in India’s diagnostics sector, with established diagnostic chains and genomics companies using acquisitions to expand geographic coverage and add specialized capabilities.

In May, Dr Lal PathLabs acquired 100% of Mumbai-based Shahbazkers Diagnostic Centre for up to Rs 20 crore, expanding its presence in Maharashtra. During the same month, MedGenome acquired a majority stake in Mumbai-based Siddhi Diagnostics & Research Centre (SDRC).

Neuberg Diagnostics also acquired a controlling stake in Mumbai-based NM Medical, adding 18 centers across Mumbai, Pune and Bengaluru. The transaction expanded Neuberg’s presence across pathology, radiology and cardiology ahead of its planned IPO.

Recent transactions indicate growing consolidation around integrated diagnostics platforms combining pathology, radiology, imaging, genomics and preventive healthcare, alongside efforts by larger players to expand into Tier-2 and Tier-3 markets.

Stay tuned for more such updates on Digital Health News